Tracy A. Jaffe

Radiation Doses from Small-Bowel Follow-Through and Abdominopelvic MDCT in Crohn's Disease

OBJECTIVE The purpose of our study was to compare organ and effective doses for small-bowel follow-through (SBFT) and abdominopelvic MDCT in adults with Crohns disease, to retrospectively evaluate the number of radiographic examinations performed for Crohns disease indications, and to identify those patients undergoing serial examinations to better delineate the use of radiology in the diagnosis and clinical management of Crohns disease. MATERIALS AND METHODS Using an anthropomorphic phantom and metal-oxide semiconductor field-effect transistor (MOSFET) dosimeters, specific organ doses were measured for 5 minutes of continuous fluoroscopy (kVp, 120; mA, 0.6) of each of the following: right lower quadrant, central abdomen, and pelvis. Effective doses were determined based on International Commission on Radiological Protection (ICRP) 60 weighting factors. Organ and effective doses were determined for abdominal and pelvic 16-MDCT: detector configuration, 16 x 0.625 mm; pitch, 1.75; 17.5 mm per rotation; rotation time, 0.5 second; 140 kVp; 340 mA. Electronic records were reviewed to determine the number of patients imaged for Crohns disease indications and the number of studies per patient. RESULTS The highest fluoroscopic organ doses were as follows: in the right lower quadrant, right kidney (0.78 cGy) and marrow (0.66 cGy); in the central abdomen, kidneys (1.5 and 1.6 cGy) and marrow (0.76 cGy); and in the pelvis, marrow (0.67-0.95 cGy). Effective doses for the right lower quadrant, central abdomen, and pelvis were 1.37, 2.02, and 3.83 mSv, respectively. For MDCT, the highest organ doses were to the liver (2.95-3.33 cGy). The effective dose for abdominopelvic MDCT was 16.1 mSv. Three hundred seventy-three patients underwent imaging for Crohns disease. The average number of SBFT and CT examinations was 1.8 and 2.3, respectively. Thirty-four (9%) of 373 patients underwent more than five CT examinations and 11 (3%) had more than 10. CONCLUSION Organ and effective doses are up to five times higher with MDCT than with SBFT. Crohns disease is more frequently imaged with CT. For a subset of patients who undergo numerous CT examinations, efforts should be made to minimize the number of CT examinations, decrease the CT dose, or consider MR enterography.

Detection of Pancreatic Tumors, Image Quality, and Radiation Dose during the Pancreatic Parenchymal Phase: Effect of a Low-Tube-Voltage, High-Tube-Current CT Technique—Preliminary Results

PURPOSE To intraindividually compare a low-tube-voltage (80 kVp), high-tube-current (675 mA) computed tomographic (CT) technique with a high-tube-voltage (140 kVp) CT protocol for the detection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase. MATERIALS AND METHODS This prospective, single-center, HIPAA-compliant study was approved by the institutional review board, and written informed consent was obtained. Twenty-seven patients (nine men, 18 women; mean age, 64 years) with 23 solitary pancreatic tumors underwent dual-energy CT. Two imaging protocols were used: 140 kVp and 385 mA (protocol A) and 80 kVp and 675 mA (protocol B). For both protocols, the following variables were compared during the pancreatic parenchymal phase: contrast enhancement for the aorta, the pancreas, and the portal vein; pancreas-to-tumor contrast-to-noise ratio (CNR); noise; and effective dose. Two blinded, independent readers qualitatively scored the two data sets for tumor detection and image quality. Random-effect analysis of variance tests were used to compare differences between the two protocols. RESULTS Compared with protocol A, protocol B yielded significantly higher contrast enhancement for the aorta (508.6 HU vs 221.5 HU, respectively), pancreas (151.2 HU vs 67.0 HU), and portal vein (189.7 HU vs 87.3 HU), along with a greater pancreas-to-tumor CNR (8.1 vs 5.9) (P < .001 for all comparisons). No statistically significant difference in tumor detection was observed between the two protocols. Although standard deviation of image noise increased with protocol B (11.5 HU vs 18.6 HU), this protocol significantly reduced the effective dose (from 18.5 to 5.1 mSv; P < .001). CONCLUSION A low-tube-voltage, high-tube-current CT technique has the potential to improve the enhancement of the pancreas and peripancreatic vasculature, improve tumor conspicuity, and reduce patient radiation dose during the pancreatic parenchymal phase.

Hepatocellular carcinoma in a North American population: Does hepatobiliary MR imaging with Gd‐EOB‐DTPA improve sensitivity and confidence for diagnosis?

To evaluate the value of hepatobiliary phase imaging for detection and characterization of hepatocellular carcinoma (HCC) in liver MRI with Gd‐EOB‐DTPA, in a North American population.

Accuracy of Abdominal Radiography in Acute Small-Bowel Obstruction: Does Reviewer Experience Matter?

OBJECTIVE The purposes of this study were to determine the accuracy of abdominal radiography in the detection of acute small-bowel obstruction (SBO), to assess the role of reviewer experience, and to evaluate individual radiographic signs of SBO. MATERIALS AND METHODS A retrospective study was performed in which the subjects were 90 patients with suspected SBO who underwent CT and abdominal radiography within 48 hours of each other. The patients were enrolled from June 1, 2003, to February 2004. Twenty-nine of the patients had proven SBO. Hard-copy radiographs were reviewed by three groups of radiologists: senior staff, junior staff, and second-year radiology residents. Each reviewer evaluated the quality of the radiographs, patient position for acquisition of the radiographs, and whether SBO was present. The reviewers rated their confidence on a five-point scale and recorded the presence or absence of specific radiographic signs of SBO. Chi-square tests were used to compare the three groups. A statistically significant finding was considered p < 0.05. Receiver operating characteristic (ROC) curves were fit with a 10-point confidence scale. RESULTS The sensitivity for SBO among the six reviewers ranged from 59% to 93%. The senior staff members were significantly more accurate. The mean sensitivity, specificity, and accuracy for all six reviewers were 82%, 83%, and 83%, respectively. Three radiographic signs were highly significant (p < 0.001): two or more air-fluid levels, air-fluid levels wider than 2.5 cm, and air-fluid levels differing more than 5 mm from one another in the same loop of small bowel. ROC analysis showed that senior staff is significantly more accurate than the other groups in the detection of acute SBO. CONCLUSION Our results confirmed that abdominal radiographs are accurate in the detection of acute SBO, that more-experienced radiologists are more accurate than less-experienced reviewers in the evaluation of abdominal radiographs, and that three types of air-fluid levels are highly predictive of the presence of SBO.

A Phase I-II Study of Docetaxel and Atrasentan in Men with Castration-Resistant Metastatic Prostate Cancer

Purpose: The primary aims of this phase I-II study were to determine the maximum tolerated dose, dose-limiting toxicity, pharmacokinetics, and preliminary efficacy of the combination of docetaxel and the endothelin A receptor antagonist atrasentan as first-line treatment for men with metastatic castration-resistant prostate cancer. Experimental Design: Patients were treated with docetaxel at doses ranging from 60 to 75 mg/m2 every 21 days, with daily oral atrasentan 10 mg starting on day 3. Patients were treated until evidence of disease progression or unacceptable toxicity. Results: Thirty-one patients were enrolled over three docetaxel dose levels (8 at 60 mg/m2, 19 at 70 mg/m2, and 4 at 75 mg/m2) including dose expansion at 70 mg/m2. The maximum tolerated dose of docetaxel was 70 to 75 mg/m2. Drug-related grade 3-4 toxicities included neutropenia (50-63%) and febrile neutropenia (16-25%); other grade 1-2 toxicities included fatigue, peripheral edema, diarrhea, headache, rhinitis, anorexia, and nausea. Confirmed prostate-specific antigen (PSA) responses were observed in 23% [95% confidence interval (95% CI), 10-41%]; the rate of >30% declines in PSA was 35% (95% CI, 19-55%). Median overall survival was 17.6 months (95% CI, 13.0-23.2) and median progression-free survival was 4.2 months (95% CI, 2.3-5.8). Significant declines in bone alkaline phosphatase and serum N-telopeptides were observed with therapy. Conclusions: The maximum tolerated dose of every-3-week docetaxel with 10 mg atrasentan is 70 to 75 mg/m2. Overall survival and progression-free survival are comparable to that seen with docetaxel and prednisone, whereas the rates of PSA decline are slightly lower than expected. A phase III study of this combination with prednisone has been initiated and is ongoing.

Practice patterns in imaging of the pregnant patient with abdominal pain : A survey of academic centers

OBJECTIVE The purpose of our study was to evaluate current practice patterns in the imaging of pregnant women with abdominal complaints. MATERIALS AND METHODS A survey was sent to the abdominal imaging division of 183 radiology residency programs in the United States. The survey asked for information regarding CT and MRI of abdominal complaints in pregnant patients. RESULTS Eighty-five surveys (46%) were returned. Sixty-three (74%) of 85 of respondents have a written departmental policy regarding imaging pregnant women. Eighty-two (96%) of 85 perform CT in pregnant women when benefits outweigh risks, with 58 (68%) obtaining written informed consent before CT examination. Eighty (94%) of 85 perform MRI in pregnant women, and 43 (51%) obtain written consent before MRI. Fifty-seven (67%) of 85 respondents do not administer gadolinium in pregnancy. In the setting of trauma, respondents choose CT over MRI for imaging in all three trimesters (75% vs 5%, 85% vs 5%, and 88% vs 4%). In the second and third trimesters, respondents prefer CT to MRI to evaluate for maternal renal calculus (35% vs 20% and 48% vs 18%, respectively), appendicitis (48% vs 38% and 58% vs 29%), and abscess (49% vs 41% and 58% vs 35%). However, MRI is preferred for imaging of appendicitis and abscesses in the first trimester (39% vs 32% and 46% vs 32%). CONCLUSION Most academic radiology departments have written policies regarding imaging of pregnant women. Academic radiologists prefer CT to MRI for imaging abdominal complaints in pregnant women, especially in the second and third trimesters.

Radiation Dose for Body CT Protocols: Variability of Scanners at One Institution

OBJECTIVE The objective of our study was to determine, using an anthropomorphic phantom, whether patients are subject to variable radiation doses based on scanner assignment for common body CT studies. MATERIALS AND METHODS Twenty metal oxide semiconductor field effect transistor dosimeters were placed in a medium-sized anthropomorphic phantom of a man. Pulmonary embolism and chest, abdomen, and pelvis protocols were used to scan the phantom three times with GE Healthcare scanners in four configurations and one 64-MDCT Siemens Healthcare scanner. Organ doses were averaged, and effective doses were calculated with weighting factors. RESULTS The mean effective doses for the pulmonary embolism protocol ranged from 9.9 to 18.5 mSv and for the chest, abdomen, and pelvis protocol from 6.7 to 18.5 mSv. For the pulmonary embolism protocol, the mean effective dose from the Siemens Healthcare 64-MDCT scanner was significantly lower than that from the 16- and 64-MDCT GE Healthcare scanners (p < 0.001). The mean effective dose from the GE 4-MDCT scanner was significantly lower than that for the GE 16-MDCT scanner (p < 0.001) but not the GE 64-MDCT scanner (p = 0.02). For the chest, abdomen, and pelvis protocol, all mean effective doses from the GE scanners were significantly different from one another (p < 0.001), the lowest mean effective dose being found with use of a single-detector CT scanner and the highest with a 4-MDCT scanner. For the chest, abdomen, and pelvis protocols, the difference between the mean effective doses from the GE Healthcare and Siemens Healthcare 64-MDCT scanners was not statistically significant (p = 0.89). CONCLUSION According to phantom data, patients are subject to different radiation exposures for similar body CT protocols depending on scanner assignment. In general, doses are lowest with use of 64-MDCT scanners.

Radiation dose reduction in abdominal computed tomography during the late hepatic arterial phase using a model-based iterative reconstruction algorithm: how low can we go?

ObjectiveThe aim of this study was to compare the image quality of abdominal computed tomography scans in an anthropomorphic phantom acquired at different radiation dose levels where each raw data set is reconstructed with both a standard convolution filtered back projection (FBP) and a full model-based iterative reconstruction (MBIR) algorithm. Materials and MethodsAn anthropomorphic phantom in 3 sizes was used with a custom-built liver insert simulating late hepatic arterial enhancement and containing hypervascular liver lesions of various sizes. Imaging was performed on a 64-section multidetector-row computed tomography scanner (Discovery CT750 HD; GE Healthcare, Waukesha, WI) at 3 different tube voltages for each patient size and 5 incrementally decreasing tube current–time products for each tube voltage. Quantitative analysis consisted of contrast-to-noise ratio calculations and image noise assessment. Qualitative image analysis was performed by 3 independent radiologists rating subjective image quality and lesion conspicuity. ResultsContrast-to-noise ratio was significantly higher and mean image noise was significantly lower on MBIR images than on FBP images in all patient sizes, at all tube voltage settings, and all radiation dose levels (P < 0.05). Overall image quality and lesion conspicuity were rated higher for MBIR images compared with FBP images at all radiation dose levels. Image quality and lesion conspicuity on 25% to 50% dose MBIR images were rated equal to full-dose FBP images. ConclusionThis phantom study suggests that depending on patient size, clinically acceptable image quality of the liver in the late hepatic arterial phase can be achieved with MBIR at approximately 50% lower radiation dose compared with FBP.

Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium.

PURPOSE To determine, in a dual-center setting, whether patients who experience transient severe motion ( TSM transient severe motion ) in the arterial phase during gadoxetate disodium-enhanced magnetic resonance (MR) imaging are at higher risk for a subsequent episode of TSM transient severe motion than patients who do not have TSM transient severe motion during initial gadoxetate disodium administration. MATERIALS AND METHODS Institutional review board approval was obtained for this retrospective, multi-institutional HIPAA-compliant study. The requirement for informed consent was waived. One hundred seventy patients each underwent two MR imaging examinations with bolus injection of gadoxetate disodium at one of two sites. Three radiologists reviewed the examinations at each site for TSM transient severe motion , based on severe arterial phase motion, despite minimal motion in the other dynamic phases. The occurrence rate of TSM transient severe motion in the second examination was compared between patients who had TSM transient severe motion in their first examination and those who did not by using the χ(2) or Fisher exact test, as appropriate. Relative risks and 95% confidence intervals ( CI confidence interval s) were calculated. RESULTS TSM transient severe motion rates in second examinations were significantly higher for patients who had TSM transient severe motion in their first examination: site 1, 67% (six of nine) vs 4% (three of 69) (P < .0001); site 2, 60% (three of five) vs 6% (five of 87) (P < .005); and both sites, 64% (nine of 14) vs 5% (eight of 156) (P < .0001). Relative risks were 15 for site 1 (95% CI confidence interval : 5, 51), 10 for site 2 (95% CI confidence interval : 3, 32), and 13 for both sites (95% CI confidence interval : 6, 27). CONCLUSION Patients who experience TSM transient severe motion during gadoxetate disodium-enhanced MR imaging are at significantly and substantially higher risk for TSM transient severe motion in the next gadoxetate disodium-enhanced examination compared with patients who do not have TSM transient severe motion during their initial gadoxetate disodium administration.

3.0- Versus 1.5-T MR Cholangiography: A Pilot Study

OBJECTIVE The purpose of our study was to evaluate quantitative and qualitative image quality of MR cholangiography at a field strength of 3.0 T compared with the standard field strength of 1.5 T. MATERIALS AND METHODS A standardized MR cholangiography sequence protocol was used for 15 healthy male volunteers (mean age +/- SD, 32.4 +/- 4.3 years) who underwent both 1.5- and 3.0-T MRI within 2 hr in an alternating fashion. Dedicated circular polarized torso coils (1.5 and 3.0 T) were used. The sequence protocol included breath-hold single-slice rapid acquisition with relaxation enhancement (slice thickness, 50 mm; orientation, coronal and +/- 20 degrees oblique coronal); breath-hold multislice HASTE (slice thickness, 3 mm; coronal only); and a non-breath-hold, respiratory-triggered 3D turbo spin-echo (TSE) T2-weighted sequence (slice thickness, 1 mm; 60 slices per slab; coronal only). Maximum intensity projections were generated from each multislice data set. Bile duct (common bile duct, right posterior segmental branch, and left hepatic duct) to periductal tissue contrast-to-noise ratios were compared at 1.5 and 3.0 T. Qualitative image analysis was performed by three independent reviewers. Qualitative analysis included delineation of the extra- and intrahepatic biliary anatomy, with specific attention given to the presence (or absence) of cystic or intrahepatic ductal variants, using a 4-point confidence scale. Statistical analysis consisted of the paired Students t test and the signed rank test. RESULTS Contrast-to-noise ratios between the bile duct and the periductal tissue were higher at 3.0 T in all three locations (common bile duct, right posterior segmental branch, and left hepatic duct). In each magnet class, the 3D TSE sequence offered the best contrast-to-noise ratio and qualitative analysis. Superiority of the 3D TSE sequence was statistically significant in all analyses. Five of the 15 volunteers had intrahepatic biliary variants that were detected with a higher level of confidence (p < 0.01) on the 3.0-T system than on the 1.5-T system. CONCLUSION Compared with MR cholangiography at 1.5 T, MR cholangiography at 3.0 T offers improved contrast-to-noise ratio and a higher level of confidence for depicting intrahepatic variants.